re: 5. files important provisional patent in the u Extract:
"This means that no one else would be able to commercialise Melanotan, in a sustained release delivery formulation, irrespective of whether it is delivered by an implant, topically, orally (a pill), or other, for 20 years."
They did refer to this in a vague form before and the more informed ones knew EPT was working on this.
We can now expect some more news about that lotion. They did say that.
It does show that although people may think there won't be any news till the next trial and therefore are not invested, this may suddenly change.
I am very happy with this development.
Share price: 91 cents (+6).
Gerry
5. data and comments. 5, page-146
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.36 |
Change
-0.080(0.52%) |
Mkt cap ! $769.1M | |||
| Open | High | Low | Value | Volume |
| $15.62 | $15.63 | $15.36 | $580.8K | 37.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 195 | $15.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.55 | 2023 | 2 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |